increased the effectiveness of a tumor vaccination by integrating CD4+ T cells, which may suggest that appropriate vaccines or drugs can be designed to increase the proportion of activated CD4 memory T cells to effectively exert antitumor effects. This evidence concerns the gene CD4 and neoplasm.